News

Published on 15 Nov 2022 on Market Watch

TherapeuticsMD Inc. stock falls Monday, underperforms market


Article preview image

Shares of TherapeuticsMD Inc. slipped 7.45% to $6.46 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.12% to 11,196.22 and Dow Jones Industrial Average falling 0.63% to 33,536.70. The stock's fall snapped a three-day winning streak. TherapeuticsMD Inc. closed $25.29 short of its 52-week high ($31.75), which the company reached on November 15th.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson rose 1.57% to $171.91, Merck & Co. Inc. rose 2.44% to $100.35, and Novartis AG ADR fell 0.68% to $83.45. Trading volume (61,580) remained 8,824 below its 50-day average volume of 70,404.

NASDAQ.TXMD price evolution
SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
25 Countries With Highest Abortion Rates

In this article, we will be taking a look at the 25 countries with highest abortion rates. If you...

Insider Monkey via Yahoo Finance 12 Mar 2024

12 Best Prenatal Vitamins For Pregnant Women

In this article, we will be taking a look at the 12 best prenatal vitamins for pregnant women. If...

Insider Monkey via Yahoo Finance 30 Jan 2024

Organogenesis (ORGO) Lags Q3 Earnings and Revenue Estimates

Organogenesis (ORGO) came out with quarterly earnings of $0.04 per share, missing the Zacks Conse...

Zacks via Yahoo Finance 21 Mar 2023

TherapeuticsMD: Challenged Women's Health Company Needs A Savior (NASDAQ:TXMD)

TherapeuticsMD (NASDAQ:TXMD), a women's health specialist company based in Boca Raton, Fla., appe...

Seeking Alpha 17 Nov 2022

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors

Shares of TherapeuticsMD Inc. shed 7.93% to $5.46 Wednesday, on what proved to be an all-around r...

Market Watch 17 Nov 2022

TherapeuticsMD Inc. stock falls Tuesday, underperforms market

Shares of TherapeuticsMD Inc. slipped 8.20% to $5.93 Tuesday, on what proved to be an all-around ...

Market Watch 16 Nov 2022

TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates

TherapeuticsMD (TXMD) came out with a quarterly loss of $3.13 per share versus the Zacks Consensu...

Zacks via Yahoo Finance 15 Nov 2022

TherapeuticsMD Inc. stock falls Monday, underperforms market

Shares of TherapeuticsMD Inc. slipped 7.45% to $6.46 Monday, on what proved to be an all-around d...

Market Watch 15 Nov 2022

TherapeuticsMD Stock: Looking To Annovera To Save The Day

Just over 12 months since our most previous commentary, shares of TherapeuticsMD are now trading...

Seeking Alpha 17 Aug 2022

TherapeuticsMD (NYSE:TXMD) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of TherapeuticsMD (NYSE:TXMD – Get Rating) from a sell rating to a...

ETF DAILY NEWS 17 Aug 2022